Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ENROLLING BY INVITATION
NCT07515391
PHASE2

Dapagliflozin Effect on Glucose Variability in Patients Post Bariatric Surgery

Sponsor: Dasman Diabetes Institute

View on ClinicalTrials.gov

Summary

This study evaluates the effect of SGLT-2 inhibitors (dapagliflozin) on the blood glucose excursions by a continuous glucose monitoring system, the incidence of hypoglycemia and hyperglycemia and change in glycated hemoglobin (HbA1c) level in people had bariatric surgery with and without type 2 diabetes.

Key Details

Gender

All

Age Range

21 Years - 70 Years

Study Type

INTERVENTIONAL

Enrollment

30

Start Date

2019-10-22

Completion Date

2026-10-22

Last Updated

2026-04-07

Healthy Volunteers

No

Interventions

DRUG

Dapagliflozin 10 MG

Dapagliflozin 10 mg drug will be administered in both arms for 12 weeks.

Locations (1)

Dasman Diabetes Institute

Kuwait City, Dasman, Kuwait